Theravance, Inc. (THRX) Reports Q4 Loss of $0.45, Sales Fall Short

Theravance, Inc. (NASDAQ: THRX) reported Q4 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $6.87 million.

For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M